Locations:

Tag: type 2 diabetes (T2D)

February 10, 2023/COVID-19

Effects of COVID-19 on Blood Sugar and Type 2 Diabetes

Cleveland Clinic analysis suggests that obtaining care for the virus might reveal a previously undiagnosed condition

January 6, 2023/Diabetes & Endocrinology/Research

Kidney Disease in Diabetes: Updates and Recommendations

Cleveland Clinic’s Endocrinology & Metabolism Institute is working to offer novel opportunities and therapies for diabetes and kidney disease

January 16, 2020/Diabetes & Endocrinology/Research

Stratifying Patients with Type 2 Diabetes for Targeted Intervention

High-need, high-cost patients identified in retrospective study

November 6, 2019/Digestive/Research

Liver Steatosis in Type 2 Diabetes is a Predictor of Improved Glycemic Outcomes after Bariatric Surgery

Research suggests T2D variants with differing metabolic responses to gastric bypass

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 10, 2019/Diabetes & Endocrinology/Research

After Metabolic Surgery, Canagliflozin Reduces BMI and Blood Glucose Levels in Patients with Type 2 Diabetes

New study finds that the average patient can expect to lose an additional 3.5kg on canagliflozin

June 7, 2019/Diabetes & Endocrinology/Research

Vitamin D3 Supplementation Fails to Significantly Lower Diabetes Risk in Patients with Pre-diabetes

Study confirms gold standards of weight loss, nutrition and exercise for diabetes prevention

BackPage 1 of 1Next